New hope for transplant patients: simpler drug combo may reduce severe side effects
NCT ID NCT06252870
First seen Feb 01, 2026 · Last updated Apr 29, 2026 · Updated 6 times
Summary
This study tests two different pre-transplant chemotherapy plans combined with a single drug (cyclophosphamide) given after transplant to prevent graft-versus-host disease (GVHD), a common and serious complication. About 82 adults with blood cancers who have a matched donor will participate. The goal is to see if this simpler approach can reduce severe GVHD while improving recovery and quality of life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Angers
RECRUITINGAngers, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Brest
RECRUITINGBrest, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CHU Nantes
RECRUITINGNantes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.